NYSE:TEVA 1 Year Share Price vs Fair Value Explore Teva Pharmaceutical Industries's Fair Values from the Community ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this ...

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is one of the top cheap pharmaceutical stocks to buy now. Leader Capital ...

Reported EPS is $0.2429 EPS, expectations were $0.63. Operator: Hello, and welcome to the Teva Pharmaceutical Industries ...

Teva Pharmaceutical Industries reported a better than expected increase in second-quarter profit on Wednesday, helped by a 26 ...

Teva Pharmaceutical Industries Ltd. announced an acceleration phase of its “Pivot to Growth” strategy aimed at transforming the company into a leading global biopharmaceutical player.

Barclays reduced their price objective on Teva Pharmaceutical Industries from $28.00 to $26.00 and set an “overweight” rating for the company in a research note on Thursday, January 30th.

Teva Pharmaceutical Industries says second-quarter profit rose 5 percent, to $241 million, while Ivax Corp, drug company that Teva plans to buy, says its earnings fell to $45.6 million (S) ...

Teva Pharmaceutical Industries announced early results of its tender offers for various series of notes, increasing total purchase caps. Quiver AI Summary Teva Pharmaceutical Industries Ltd ...